BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3276217)

  • 1. Change of insulin action with aging in conscious rats determined by euglycemic clamp.
    Nishimura H; Kuzuya H; Okamoto M; Yoshimasa Y; Yamada K; Ida T; Kakehi T; Imura H
    Am J Physiol; 1988 Jan; 254(1 Pt 1):E92-8. PubMed ID: 3276217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin action during fasting and refeeding in rat determined by euglycemic clamp.
    Pénicaud L; Kandé J; Le Magnen J; Girard JR
    Am J Physiol; 1985 Nov; 249(5 Pt 1):E514-8. PubMed ID: 3904481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation.
    Gupta G; Cases JA; She L; Ma XH; Yang XM; Hu M; Wu J; Rossetti L; Barzilai N
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E985-91. PubMed ID: 10826999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between changes in body composition and insulin responsiveness in models of the aging rat.
    Barzilai N; Rossetti L
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E591-7. PubMed ID: 7573438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in body composition are associated with hepatic insulin resistance in conscious rats.
    Barzilai N; Rossetti L
    Am J Physiol; 1996 Jun; 270(6 Pt 1):E930-6. PubMed ID: 8764175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
    Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
    J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo insulin resistance during nonlethal hypermetabolic sepsis.
    Lang CH; Dobrescu C
    Circ Shock; 1989 Jun; 28(2):165-78. PubMed ID: 2661048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in older rats.
    Narimiya M; Azhar S; Dolkas CB; Mondon CE; Sims C; Wright DW; Reaven GM
    Am J Physiol; 1984 May; 246(5 Pt 1):E397-404. PubMed ID: 6426315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats.
    Kraegen EW; James DE; Jenkins AB; Chisholm DJ
    Am J Physiol; 1985 Mar; 248(3 Pt 1):E353-62. PubMed ID: 3883806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin binding and action in isolated rat hepatocytes: effect of obesity and fasting.
    Frank HJ; Davidson MB
    Am J Physiol; 1982 Sep; 243(3):E240-5. PubMed ID: 7051855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentobarbital reduces basal liver glucose output and its insulin suppression in rats.
    Clark PW; Jenkins AB; Kraegen EW
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E701-7. PubMed ID: 2185651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postreceptor defect in insulin action in streptozotocin-induced diabetic rats.
    Nishimura H; Kuzuya H; Okamoto M; Yamada K; Kosaki A; Kakehi T; Inoue G; Kono S; Imura H
    Am J Physiol; 1989 May; 256(5 Pt 1):E624-30. PubMed ID: 2655470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose uptake and insulin sensitivity in rat muscle: changes during 3-96 weeks of age.
    Goodman MN; Dluz SM; McElaney MA; Belur E; Ruderman NB
    Am J Physiol; 1983 Jan; 244(1):E93-100. PubMed ID: 6336911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats.
    Borel MJ; Beard JL; Farrell PA
    Am J Physiol; 1993 Mar; 264(3 Pt 1):E380-90. PubMed ID: 8460685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole body and hepatic insulin action in normal, starved, and diabetic rats.
    Koopmans SJ; de Boer SF; Sips HC; Radder JK; Frölich M; Krans HM
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E825-32. PubMed ID: 2058659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility to insulin resistance associated with abdominal obesity in aging rats.
    Catalano KJ; Bergman RN; Ader M
    Obes Res; 2005 Jan; 13(1):11-20. PubMed ID: 15761159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
    Kolterman OG; Insel J; Saekow M; Olefsky JM
    J Clin Invest; 1980 Jun; 65(6):1272-84. PubMed ID: 6997333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.